Beneficial effects of curtailing immune susceptibility in an Alzheimer’s disease model

BACKGROUND: Currently, there are no effective therapeutic options for Alzheimer’s disease, the most common, multifactorial form of dementia, characterized by anomalous amyloid accumulation in the brain. Growing evidence points to neuroinflammation as a major promoter of AD. We have previously shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Benedetto, Giulia, Burgaletto, Chiara, Carta, Anna R., Saccone, Salvatore, Lempereur, Laurence, Mulas, Giovanna, Loreto, Carla, Bernardini, Renato, Cantarella, Giuseppina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693231/
https://www.ncbi.nlm.nih.gov/pubmed/31409354
http://dx.doi.org/10.1186/s12974-019-1554-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693231/
https://www.ncbi.nlm.nih.gov/pubmed/31409354
http://dx.doi.org/10.1186/s12974-019-1554-9

Ejemplares similares